Echo IQ Limited (ASX: EIQ) has delivered a concise update showing rising clinical usage for EchoSolv™ AS, clear progress on EchoSolv™ HF’s FDA pathway, and expanding commercial channels in the US and Europe. The near-term catalysts are anchored in actual hospital integrations, validation work nearing completion, and newly appointed US key opinion leaders guiding adoption.

Coffee with Samso Episode 207 is all about a company that is feeling left behind in the midst of a unprecedented gold price rush. Gold miners, the producing companies on the ASX, are all buoyant and experiencing an emotional high on valuation. Shareholders are in a state of euphoria but in the rush, there are always some hidden value. The hidden value that is typically brushed aside by the juggernaut of cash producing gold miners speeding past the sights of investors.